Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.19 -0.60 (-0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Arrowhead Pharmaceuticals (ARWR) recorded Return on Capital Employed [ROCE] of -11.88% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 3.46 percentage points from -8.42% a year earlier but up 1.65 percentage points from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals reported Return on Capital Employed [ROCE] of 9.22%, up 79.97 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +32.77 percentage points (FY2020 to FY2025).
  • Across earlier fiscal years, Return on Capital Employed [ROCE] came in at -70.76% in FY2024 (-37.87 pp), -32.89% in FY2023 (-1.14 pp), -31.75% in FY2022 (-0.03 pp) and -31.72% in FY2021 (-8.17 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -66.51% in fiscal Q3 2024 to 26.20% in fiscal Q1 2026 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last eight quarters, with an average year-over-year change of +27.33 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 89.88 percentage points in fiscal Q1 2026, against a drop of 46.56 percentage points in fiscal Q2 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -13.52% (Q2 2026), 26.20% (Q1 2026) and 8.28% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Arrowhead Pharmaceuticals 9.06 Bn 3.84 Bn - -11.88%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.88%
Mar 31, 2026 -13.52%
Dec 31, 2025 26.20%
Sep 30, 2025 8.28%
Jun 30, 2025 -8.42%
Mar 31, 2025 -11.05%
Dec 31, 2024 -63.68%
Sep 30, 2024 -66.15%
Jun 30, 2024 -66.51%
Mar 31, 2024 -65.30%
Dec 31, 2023 -47.36%
Sep 30, 2023 -30.36%
Jun 30, 2023 -23.34%
Mar 31, 2023 -18.74%
Dec 31, 2022 -23.49%
Sep 30, 2022 -30.62%
Jun 30, 2022 -26.62%
Mar 31, 2022 -22.27%
Dec 31, 2021 -35.05%
Sep 30, 2021 -25.87%
API Access

Arrowhead Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARWR&period=max&api_key=YOUR_API_KEY